Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib-Reference-Cited by-同舟云学术

Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib

Published:2011-12 Issue:12 Volume:17 Page:1874-1877
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sharma Manish,Ravandi Farhad,Bayraktar Ulas Darda,Chiattone Alexandre,Bashir Qaiser,Giralt Sergio,Chen Julianne,Qazilbash Muzaffar,Kebriaei Partow,Konopleva Marina,Andreeff Michael,Cortes Jorge,McCue Deborah,Kantarjian Hagop,Champlin Richard E.,de Lima Marcos

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. The roles of FLT3 in hematopoiesis and leukemia;Gilliland;Blood,2002

2. Tandem-duplicated FLT3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines;Hayakawa;Oncogene,2000

3. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia;Kiyoi;Blood,1999

4. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

5. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the FLT3 gene;Rombouts;Leukemia,2000

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in allogeneic transplantation for acute myeloid leukemia;Current Opinion in Oncology;2023-08-30

2. Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption;Frontiers in Oncology;2023-03-15

3. How acute myeloid leukemia (AML) escapes from FMS-related tyrosine kinase 3 (FLT3) inhibitors? Still an overrated complication?;Cancer Drug Resistance;2023

4. Next-Generation FLT3 Inhibitors for the Treatment of FLT3-Positive AML;Pathogenesis and Treatment of Leukemia;2023

5. FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation;International Journal of Hematology;2022-04-23